Copper peptide is shorthand for GHK-Cu — the tripeptide-copper complex glycyl-L-histidyl-L-lysine bound to copper(II) — and the broader category of copper-containing peptides used in skincare and longevity products. Topical GHK-Cu has the strongest evidence base among research peptides, going back decades on wound healing, collagen and elastin synthesis, and anti-inflammatory effects.
2026 has been the year copper peptides crossed into mainstream consumer skincare. BoomRx launched a copper-peptide skincare line at the A4M Longevity SpringFest in April; Neurogan Health expanded with a 2% GHK-Cu topical body care backed by a 12-week clinical trial reporting 32.8% wrinkle-depth reduction and 20–30% improvement in skin firmness. Search interest in GHK-Cu has grown over 1,000% year-over-year per published trend data.
The regulatory split: topical GHK-Cu is a cosmetic ingredient, while injectable GHK-Cu sits in the FDA Category 2 reclassification queue alongside BPC-157 and others ahead of the July 23–24 PCAC meeting. Stories here cover product launches, clinical evidence, and the topical-vs-injectable distinction. See #ghk-cu, #anti-aging, and #skincare.
Fast Millennial Mode LLC, founded by entrepreneur Elena Catalina Radu, announced the official launch of Sacred Eye Beauty's flagship 30-Day Ritual on Sunday June 28, 2026. The system has two components. The Inside-Out Activator combines NAD+, spermidine, vitamin C, and MODS Max sublingual-delivery technology in a single daily dose targeting cellular-wellness and healthy-aging markers. The Skin Magic Tablets combine GHK-Cu (copper tripeptide-1), PQQ (pyrroloquinoline quinone), and methylene blue for skin and broader cellular support. The launch fits squarely inside the 2026 mainstream-consumer cosmetic peptide wave that this site has tracked across June: Moes Group's June 6 GHK-Cu private-label manufacturing rollout, CKYN's June 20 GHK-Cu launch, Cosmetics Business's June 2026 feature on eight peptide-anchored beauty launches (Shiseido Ultimune, YSE Beauty Xtreme Glow), and the K-beauty PDRN-peptide-exosome stack. Sacred Eye's differentiator is the inside-out positioning, pairing oral supplementation with topical-equivalent claims. The consumer-channel growth runs in parallel to the regulatory thread: GHK-Cu is one of the seven peptides on the FDA Pharmacy Compounding Advisory Committee's July 23-24 agenda for 503A bulks list eligibility.
CKYN LLC, a Kirkland, Washington-based skincare company, launched The Complete CKYN Protocol on June 20, 2026 — a three-step daily skincare system built entirely around GHK-Cu (Copper Tripeptide-1). The protocol comprises the Morning GHK-Cu Perfecting Lotion, Daytime GHK-Cu Tallow Balm, and Night-Time GHK-Cu Firming Serum. The product positioning anchors on six bioactives instead of the typical 20+ ingredient prestige skincare formulation, with concentrations targeted to clinical-study levels: published GHK-Cu research has shown 22% visibly firmer skin and 16% reduction in fine-line appearance after 12 weeks of consistent twice-daily application. GHK-Cu was first isolated from human plasma in 1973 by Dr. Loren Pickart and has accumulated four decades of cosmetic-science evidence. CKYN sits alongside Italgel avvera (June 12 launch) and GELITA CURADERM (Vitafoods Europe 2026) in the active 2026 cosmetic-peptide launch cycle.
Moes Group, a California-based private and white-label skincare manufacturer, announced June 6 that it is producing blue copper peptide (GHK-Cu / copper tripeptide-1) skincare and haircare formulations for brand partners, with cosmetic-grade GHK-Cu in stock and production already running. The launch arrives as the topical GHK-Cu market broadens after FDA materials in May indicated that non-injectable GHK-Cu would return to Category 1 under the 503A process; the injectable form remains pending the second PCAC review scheduled before February 2027.
The copper-peptide (GHK-Cu, copper tripeptide-1) cosmetic category continued its 2026 surge through late May. Neurogan Health's 2% GHK-Cu body-care line documented a 32.8% reduction in wrinkle depth and 20-30% improvement in skin firmness in 12-week clinical testing. Auro Wellness, founded by peptide-delivery specialist Nayan Patel, anchors its copper-tripeptide serum on a proprietary delivery system. GHK-Cu is the fastest-growing peptide search term of 2026, with consumer interest spanning skin rejuvenation, hair loss, and systemic longevity. GHK-Cu activates over 4,000 human genes involved in collagen synthesis, anti-inflammation, and tissue remodeling. The cosmetic surge runs in parallel with the FDA's regulatory cycle: injectable GHK-Cu is on the docket for the February 2027 PCAC meeting alongside Melanotan II, LL-37, Dihexa, and PEG-MGF, while the topical cosmetic form remains in the lighter-regulated personal-care channel. The category illustrates the consumer end of the peptide landscape maturing alongside the therapeutic pipeline.
Neurogan Health expanded its product line with a topical 2% GHK-Cu copper peptide body care, supported by a 12-week clinical trial reporting 32.8% reduction in wrinkle depth and 20–30% improvement in skin firmness. The launch lands in a 2026 GHK-Cu market characterized by surging consumer interest — the peptide is the fastest-growing skincare ingredient by search volume, with patient interest spanning skin rejuvenation, hair loss, and systemic longevity. Topical GHK-Cu has the strongest evidence base among research peptides, going back decades on wound healing and collagen synthesis, and topical applications avoid the regulatory gray zone around the injectable formulation.
Pharmaceutical platform BoomRx debuted its copper peptide skincare line at the A4M Longevity SpringFest conference in West Palm Beach. The flagship product features Copper Tripeptide-1 (GHK-Cu), targeting med-spa and wellness practices already offering GLP-1, hormone, and hair loss treatments.
Dermatology Times Q&A explores advances in GHK-Cu delivery for skincare, discussing how the peptide complexes with copper in human plasma and new formulation approaches to improve topical efficacy.